Millions of Americans can't obtain promising new weight loss drugs because Medicare won't pay

Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

Related Keywords

United States ,Washington ,Michigan ,Americans ,America ,Brad Wenstrup ,Mark Mcclellan ,Raul Ruiz ,Ted Kyle ,Tom Carper ,Novo Nordisk Wegovy ,Eli Lilly Zepbound ,Andrew Kraftson ,David Schweikert ,Judy Chu ,Eli Lilly ,Darius Lakdawalla ,Oprah Winfrey ,Medicaid Services ,University Of Michigan Weight Navigator ,University Of Southern California Schaeffer Center ,Schaeffer Center ,Centers For Medicare ,Vanderbilt University ,Associated Press ,Drug Administration ,Obesity Society ,Congressional Budget Office ,Novo Nordisk ,Centers For Disease ,Disease Control ,Southern California ,Weight Navigator ,Pharmaceutical Research ,Reduce Obesity Act ,Health ,News ,